Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma
1 clinical trials · Condition
◉ Watch Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma (NCT03113500) | City of Hope Medical Center | 2017-05-25 |
Track Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.